How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab
- PMID: 38644777
- DOI: 10.1093/bjd/ljae165
How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab
Conflict of interest statement
Conflicts of interest C.E.H.G. reports being a speaker and/or advisor for and/or receiving research funds from Argenx, Blueprint Medicines, Celltrion Inc., Novartis and Sanofi. E.K. reports being a speaker and advisor for Novartis, Menarini, LaRoche Posay, Sanofi, Bayer, Abdi Ibrahim and Pfizer.
Comment on
-
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.Br J Dermatol. 2024 Jul 16;191(2):187-199. doi: 10.1093/bjd/ljae067. Br J Dermatol. 2024. PMID: 38367194 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources